Compounds > n,n-di-n-hexyl-2-(4-fluorophenyl)indole-3-acetamide
Page last updated: 2024-09-03

n,n-di-n-hexyl-2-(4-fluorophenyl)indole-3-acetamide and Central Nervous System Diseases

n,n-di-n-hexyl-2-(4-fluorophenyl)indole-3-acetamide has been researched along with Central Nervous System Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ittner, LM; Kassiou, M; Scarf, AM1

Reviews

1 review(s) available for n,n-di-n-hexyl-2-(4-fluorophenyl)indole-3-acetamide and Central Nervous System Diseases

ArticleYear
The translocator protein (18 kDa): central nervous system disease and drug design.
    Journal of medicinal chemistry, 2009, Feb-12, Volume: 52, Issue:3

    Topics: Acetamides; Apoptosis; Central Nervous System; Central Nervous System Diseases; Drug Design; Humans; Indoleacetic Acids; Indoles; Mitochondrial Membranes; Neurodegenerative Diseases; Phenyl Ethers; Pyrazoles; Pyrimidines; Receptors, GABA

2009